BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4022524)

  • 1. Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome.
    Chen KT; Schooley JL; Flam MS
    Obstet Gynecol; 1985 Sep; 66(3 Suppl):93S-94S. PubMed ID: 4022524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations.
    Deligdisch L; Gil J; Kerner H; Wu HS; Beck D; Gershoni-Baruch R
    Cancer; 1999 Oct; 86(8):1544-50. PubMed ID: 10526284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary peritoneal carcinomatosis after prophylactic oophorectomy.
    Kemp GM; Hsiu JG; Andrews MC
    Gynecol Oncol; 1992 Dec; 47(3):395-7. PubMed ID: 1473756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.
    Piver MS; Jishi MF; Tsukada Y; Nava G
    Cancer; 1993 May; 71(9):2751-5. PubMed ID: 8467455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
    Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
    Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K
    Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylactic oophorectomy (author's transl)].
    Schweppe KW; Beller FK
    Geburtshilfe Frauenheilkd; 1979 Dec; 39(12):1024-32. PubMed ID: 520781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of prophylactic oophorectomy in cancer prevention.
    Averette HE; Nguyen HN
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S38-41. PubMed ID: 7835808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case.
    Kaplan EJ; Caputo TA; Shen PU; Sassoon RI; Soslow RA
    Gynecol Oncol; 1998 Aug; 70(2):289-94. PubMed ID: 9740708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospectively detected cancer in familial breast/ovarian cancer screening.
    Dørum A; Heimdal K; Løvslett K; Kristensen G; Hansen LJ; Sandvei R; Schiefloe A; Hagen B; Himmelmann A; Jerve F; Shetelig K; Fjaerestad I; Tropé C; Møller P
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):906-11. PubMed ID: 10577622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial peritoneal ovarian carcinomatosis: a new clinical entity?
    Lynch HT; Bewtra C; Lynch JF
    Med Hypotheses; 1986 Oct; 21(2):171-7. PubMed ID: 3641031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial ovarian cancer.
    Volm T
    Curr Womens Health Rep; 2002 Feb; 2(1):34-8. PubMed ID: 12112981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic oophorectomy in inherited breast/ovarian cancer families.
    Struewing JP; Watson P; Easton DF; Ponder BA; Lynch HT; Tucker MA
    J Natl Cancer Inst Monogr; 1995; (17):33-5. PubMed ID: 8573450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial ovarian cancer syndrome].
    Bösze P
    Orv Hetil; 1994 Feb; 135(9):459-64. PubMed ID: 8139849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.
    Villella JA; Parmar M; Donohue K; Fahey C; Piver MS; Rodabaugh K
    Gynecol Oncol; 2006 Sep; 102(3):475-9. PubMed ID: 16473397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary intraperitoneal neoplasia resembling ovarian carcinoma after removal of benign ovaries.
    White CD
    W V Med J; 1993 Jul; 89(7):282-3. PubMed ID: 8351900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal carcinomatosis in women with a history of breast cancer.
    Garg R; Zahurak ML; Trimble EL; Armstrong DK; Bristow RE
    Gynecol Oncol; 2005 Oct; 99(1):65-70. PubMed ID: 15979132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.